Anti-CXCL14 antibody [EPR22807-28]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal CXCL14 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Transfected cell lysate - Human, Mouse, Rat, Human samples. Cited in 7 publications.
View Alternative Names
MIP2G, NJAC, SCYB14, PSEC0212, UNQ240/PRO273, CXCL14, C-X-C motif chemokine 14, Chemokine BRAK, MIP-2G, Small-inducible cytokine B14
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-CXCL14 antibody [EPR22807-28] (AB264467)
Intracellular flow cytometric analysis of [4% paraformaldehyde-fixed, 90% methanol-permeabilized HEK-293T (human embryonic kidney epithelial cell) (transfected with myc-tagged CXCL14 expression vector) cells labeling CXCL14 with ab264467 at 1/500 dilution (Right) compared with a Isotype control details (ab172730) (Left). Goat anti rabbit IgG (Alexa Fluor® 488, ab150079), at 1/2000 dilution was used as the secondary antibody.
Cells were stained with rabbit IgG (Left) or ab264467 (Right). Then stained with anti-myc tag conjugated to Alexa Fluor® 488.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CXCL14 antibody [EPR22807-28] (AB264467)
Immunofluorescent analysis of 4% paraformaldehyde-fixed,0.1% Triton X-100 permeabilized HEK-293T (human embryonic kidney epithelial cell) (transfected with myc-tagged CXCL14 expression vector) cells labeling CXCL14 with ab264467 at 1/100 dilution, followed by ab150077 AlexaFluor®488 Goat anti-Rabbit secondary secondary antibody at 1/1000 dilution (Green). The myc tag is also detected with a Myc-Tag (9B11) Mouse mAb (Alexa Fluor® 647 Conjugate) (Red). Confocal image showing cytoplasmic staining in 293T cells transfected with myc-tagged CXCL14 expression vector. The nuclear counter stain is DAPI (Blue).
Secondary antibody only control : Used PBS instead of primary antibody, followed by ab150077 AlexaFluor®488 Goat anti-Rabbit secondary secondary antibody at 1/1000 dilution.
- WB
Unknown
Western blot - Anti-CXCL14 antibody [EPR22807-28] (AB264467)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
The expression profile and molecular weight observed is consistent with what has been described in the literature (PMID : 15843547, 2602137, 28359053).
This blot was developed using a higher sensitivity ECL substrate.
All lanes:
Western blot - Anti-CXCL14 antibody [EPR22807-28] (ab264467) at 1/1000 dilution
Lane 1:
Human skin lysate at 10 µg
Lane 2:
Rat skin lysate at 10 µg
Lane 3:
RAW 264.7 (mouse abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 4:
Mouse skin lysate at 20 µg
Lane 5:
Rat lung lysate at 20 µg
Lane 6:
Mouse lung lysate at 10 µg
Secondary
Lanes 1 - 2:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Lanes 3 - 6:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 13 kDa
Observed band size: 14 kDa
false
- WB
Unknown
Western blot - Anti-CXCL14 antibody [EPR22807-28] (AB264467)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-CXCL14 antibody [EPR22807-28] (ab264467) at 1/1000 dilution
Lane 1:
HEK-293 (human embryonic kidney) transfected with an empty vector (vector control), containing a myc-His-tag®, whole cell lysate at 10 µg
Lane 2:
HEK-293 transfected with CXCL14 (WT) expression vector containing a myc-His-tag®, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 13 kDa
false
Related conjugates and formulations (1)
-
Anti-CXCL14 antibody [EPR22807-28] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CXCL14 influences cell signaling pathways that regulate immune responses and tissue homeostasis. It engages in the attraction of immune cells like monocytes and dendritic cells to specific tissues. While CXCL14 is not part of a larger complex its function in modulating local immune environments is significant. This protein’s role in immune surveillance contributes to both normal physiological conditions and response to pathology.
Pathways
Interactions of CXCL14 involve key signaling cascades. The protein is part of pathways that regulate inflammation and cell movement including the MAPK and PI3K signaling pathways. Related proteins such as CXCR4 and CCR2 interact within these pathways to coordinate cell signaling and chemotaxis. These interactions facilitate communication between cells and regulate responses essential for maintaining tissue integrity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:7872 PubMed40849297
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 16:1614683 PubMed40589739
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bone research 12:27 PubMed38714649
2024
Applications
Unspecified application
Species
Unspecified reactive species
Arteriosclerosis, thrombosis, and vascular biology 44:653-665 PubMed38269590
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:215 PubMed36973255
2023
Applications
Unspecified application
Species
Unspecified reactive species
Respiratory medicine 185:106462 PubMed34082276
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental cell research 400:112492 PubMed33529710
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com